Cluster Health & Mission Cancer Brokerage Event

28 Sept 2026 | Brussels, Belgium

Project cooperationUpdated on 11 September 2026

Expertise for HORIZON-MISS-2027-02-CANCER-05

Medical Oncologist/Associate professor/ Lead of Tumor Molecular Board at Lithuanian university of health sciences

Kaunas, Lithuania

About

LSMU Kauno Klinikos offers a strong clinical environment for the evaluation and validation of innovative cancer technologies, diagnostics, medical devices, and therapeutic solutions. Through the Molecular Tumour Board and advanced oncology services, the institution has experience assessing the clinical utility of novel precision medicine approaches. LSMU KK can contribute expertise in clinical feasibility studies, patient recruitment, technology assessment, implementation research, and outcome evaluation. The institution is well positioned to support translational activities from innovation development to real-world clinical application. Dr. Kupčinskaitė and her team are interested in partnerships that promote affordable, effective, and clinically validated innovations capable of improving cancer diagnosis and treatment across European healthcare systems.

Similar opportunities